SCHEMBL5569550

SCHEMBL5569550

CC(C)(CN)NC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 6/20 0.48
▸ F2 P00734 1/20 0.48
▸ HTT P42858 1/20 0.42
▸ HDAC4 P56524 2/20 0.41
▸ P2RY1 P47900 1/20 0.40
▸ HSD11B1 P28845 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 2/20 0.37
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ FPR2 P25090 1/20 0.35
▸ CCR1 P32246 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569549 0.86 F10 (0.48) F10F2HTTHDAC4P2RY1
SCHEMBL5566765 0.81 F10 (0.50) F10F2HTTHDAC4P2RY1
SCHEMBL5570726 0.79 F10 (0.50) F10F2NPSR1POLB
SCHEMBL5570744 0.79 F10 (0.48) F10F2HDAC4P2RY1SLC6A2
SCHEMBL5567062 0.77 F10 (0.46) F10F2P2RY1KCNH2SLC6A2
SCHEMBL5570724 0.77 F10 (0.50) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5642352 0.76 F10 (0.51) F10F2P2RY1HSD11B1SLC6A2
SCHEMBL5670078 0.76 F10 (0.65) F10F2P2RY1SLC6A2SLC6A4
SCHEMBL5567238 0.76 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5570741 0.76 F10 (0.48) F10F2P2RY1HSD11B1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
Send feedback